DEFERASIROX TEVA 900 mg, comprimé pelliculé — plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930247839
  • CIP7 3024783
  • CIS 64315140

What the source publishes

Holder
TEVA SANTE
Active ingredients
DÉFÉRASIROX
Form
comprimé pelliculé
Package
plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2022-02-17
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930247839
{
  "cis": "64315140",
  "cip7": "3024783",
  "form": "comprimé pelliculé",
  "name": "DEFERASIROX TEVA 900 mg, comprimé pelliculé — plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)",
  "cip13": "3400930247839",
  "holder": "TEVA SANTE",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA SANTE"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "647.20",
  "authorisedOn": "2022-02-17",
  "compositions": [
    {
      "name": "DÉFÉRASIROX",
      "nature": "SA",
      "strength": "900 mg",
      "linkageNumber": "1",
      "substanceCode": "87487",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "646.18",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "DEFERASIROX TEVA 900 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) aluminium PVC polyéthylène PVDC de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2026-08-14",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DÉFÉRASIROX"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription initiale hospitalière semestrielle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930247839"